coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Blackpool North PCN, Blackpool (LAD) · Health Inequalities Profile

    PCN U82077 · NHS Lancashire and South Cumbria Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    27,163

    Registered population

    58.5% aged 18–64

    24.1%

    Aged 65+

    ICB 20.0% · England 17.9%

    4.8%

    Ethnic minority (non-White)

    2.4% Asian · England 9.6%

    35.6%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~9,826

    Core20 residents (est.)

    Resident basis; registered basis ~9,566 · see page 3

    5,978

    Hypertension register

    +5.88% in 3 yrs · England +5.60%

    499

    SMI register

    16.3% of Blackpool (LAD)'s

    1,111

    COPD register

    Reviews -1.62% in 3 yrs

    Forecast to 2030

    6,604

    Hypertension patients, 2077

    +626 on today

    71.0%

    QRISK ≥20% on statins, 2077

    +3.73pp over 3 yrs

    7.2%

    Cancer prevalence, 2077

    England 4.5%

    Three things the board should see

    61.4%
    Asthma review coverage trails England and ICB.

    Annual asthma review coverage is 61.4% against 65.7% in England, leaving about 810 of 2,104 register patients without a recorded review.

    86.0%
    Pre-school MMR2 coverage sits below 95.0% target.

    Age-5 MMR2 reaches 86.0% (cohort 57), sitting 9 pp below the 95.0% target, with a 10.5 pp MMR1-to-MMR2 difference at Glenroyd Medical Centre.

    +15.9%
    Diabetes HbA1c and SMI checks rose strongly.

    Three-year non-frail diabetes HbA1c control rose +15.9% (England +4.4%), while mental health register BMI recording rose +13.3 pp (England +5.1 pp).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ reach 24.1%, sitting 6.2 percentage points above England

    Blackpool North PCN registers 27,163 patients across North Shore Surgery (13,850) and Glenroyd Medical Centre (13,313). Both serve older populations, with 24.1% (6,538 patients) aged 65+ overall (Glenroyd Medical Centre 24.8%, North Shore Surgery 23.4%), compared with 20.4% in Blackpool (LAD), 20.0% in the ICB, and 17.9% in England. Patients aged 18-64 account for 58.5% and aged 0-17 represent 17.4%. Census resident estimates show 95.2% White ethnicity (Blackpool 94.7%, ICB 87.8%, England 81.1%), with a 4.8% ethnic minority share including 2.4% Asian or Asian British. This older demographic may heighten multi-morbidity care demand.

    Age profile

    0–1717.4%
    18–6458.5%
    65+24.1%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White95.2%
    Asian2.4%
    Mixed1.5%
    Other0.6%
    Black0.4%

    Older people · falls rows are Blackpool (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Blackpool LA)1,6472,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Blackpool LA)9551,0219552024/25
    Falls deaths, all ages, per 100,000 (Blackpool LA)16.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    At 35.6%, Core20 deprivation exceeds England and is balanced across both practices

    Core20 patients comprise 35.6% of the registered list (weighted practice share 35.2%; England 21.0%; Blackpool LAD 55.1%), alongside about 9,800 LSOA residents. Deprivation is balanced, spanning 34.3% at Glenroyd Medical Centre (4,565 estimated patients) to 36.1% at North Shore Surgery (5,001 estimated patients), a 1.8 pp spread. On a severe mental illness register of 499 patients (1.8% vs England 1.0%), checks trail England for blood pressure (78.5% vs 83.4%) and BMI (74.7% vs 82.1%). Balanced deprivation indicates shared outreach can address physical check shortfalls across both practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    North Shore36.1% · 5,001 patients
    Glenroyd34.3% · 4,565 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    499

    SMI register

    1.79% recorded prevalence

    168

    Learning disability register

    0.60% recorded prevalence

    32

    Care homes, 874 beds

    In the PCN catchment

    10.9%

    Provide unpaid care

    Blackpool (LAD), Census 2021

    The PCN records 499 severe mental illness patients (1.8% prevalence; Blackpool 1.7%, ICB 1.2%, England 1.0%) and 168 learning disability patients (0.6%, matching England). Catchment capacity includes 32 care homes with 874 beds, though sites do not establish PCN registration. Higher severe mental illness prevalence than regional and national comparators indicates ongoing routine review requirements across PCN practices.

    Severe mental illness: physical health checks

    On a 1.8% severe mental illness register (England 1.0%), annual physical checks trail England for blood pressure (78.5% vs 83.4%) and BMI (74.7% vs 82.1%), led by lower recording at Glenroyd Medical Centre (BP 72.6%; BMI 68.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,978

    Hypertension register

    +5.88%

    Register growth, 3 yrs

    Blackpool (LAD) +5.85% · England +5.60%

    −0.31pp

    BP control, under 80

    ≤140/90 · +0.96pp aged 80+

    +626

    More patients by 2030

    Forecast 6,604 (24.08%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 21.5% (5,978 patients), above England (15.2%), Blackpool (19.4%) and the ICB (17.2%), alongside high stroke (2.8% vs England 1.9%) and heart failure prevalence (2.4% vs England 1.1%). However, blood pressure control has slipped over three years: patients treated to target changed -0.4% (England +3.6%) and control in under-80s changed -0.5% (England +3.2%). Additionally, hypertension patients with a recent blood pressure reading reach 86.9%, below England (90.0%), with North Shore Surgery at 84.8% compared to Glenroyd Medical Centre at 89.0%. Trailing national control trends alongside high cardiovascular prevalence suggests routine recall and medication titration should be prioritised, starting at North Shore Surgery.

    Lipids and statins

    Statin treatment in diabetes without cardiovascular disease is 68.4%, below England (73.2%), Blackpool (71.2%) and the ICB (71.3%), with North Shore Surgery at 59.6% and Glenroyd Medical Centre at 78.1%. Lower secondary prevention coverage than England suggests an opportunity to expand proactive lipid-lowering therapy in diabetic patients, focusing first on North Shore Surgery.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202675,943£1.10£1.64£1.86£83,537
    Cardiovascular (all), 2025112,593£3.05£3.38£3.33£343,409

    For lipid-regulating drugs in 2026, the PCN prescribed 75,943 items at £1.10 per item, below England (£1.86), Blackpool (£1.49) and the ICB (£1.64), spending £57,717 less than at England's unit cost. Spending less per item than England may offer flexibility when reviewing lipid prescribing volume.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +7.32%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.36%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 4.0% (1,111 patients) against 1.9% in England, yet 12-month review coverage fell 1.6% over three years (England +2.8%) to 74.2% (England 76.4%; ICB 76.9%). The asthma register covers 2,104 patients (8.0% vs England 6.6%), but annual reviews reach 61.4% (England 65.7%), leaving about 810 patients unreviewed. Furthermore, asthma prescribing for ages 5-19 is 2,555 items per 1,000 (England 1,488), while second-hand smoke recording for ages 6-19 is 67.2% (England 78.8%).

    Cancer register and children's immunisation

    Cancer prevalence is 5.6% (1,566 patients) against 3.8% in England. Early childhood immunisation is strong, with 24-month MMR1 at 97.7%. However, age-5 MMR2 coverage drops to 86.0%, below the 95.0% target by 9 pp, alongside an 87.7% 4-in-1 booster rate. At age 5, same-cohort MMR1 to MMR2 shows a 5.2 pp gap across the PCN, widening to a 10.5 pp difference at Glenroyd Medical Centre (94.7% vs 84.2%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.8%

    England 91.0%

    6-in-1 complete primary course at 24 months95.3%

    England 92.2%

    MMR dose 1 at 24 months97.7%

    England 88.3%

    MMR dose 2 at age 586.0%

    England 82.8%

    4-in-1 pre-school booster at age 587.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of cancers across NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2 (4,642 of 8,863 known-stage cancers; 74.6% known-stage share), trailing England (55.3%) and sitting 22.6 pp below the 75.0% national ambition by 2028. Across the ICB, early-stage share fell 1.2 pp from 53.6% in 2013, requiring about 2,010 extra early-stage cases annually to achieve 75.0%. Early detection varied widely by site, including 86.0% in breast, 44.2% in bowel and 31.1% in lung cancer. These wider-system figures do not reflect PCN performance, though PCN breast screening coverage lags at 67.0% (England 69.9%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the cancer 62-day referral to treatment standard (below the 85.0% standard by 17.5 pp), behind Lancashire Teaching Hospitals NHS Foundation Trust (75.0%), University Hospitals of Morecambe Bay NHS Foundation Trust (72.4%), NHS Lancashire and South Cumbria Integrated Care Board (73.6%) and England (71.2%). On the 28-day faster diagnosis standard, Blackpool Teaching Hospitals NHS Foundation Trust reached 71.4% (standard 75.0%), trailing Lancashire Teaching Hospitals NHS Foundation Trust (82.9%), the ICB (78.4%) and England (79.3%). Diagnostic 6+ week waits stood at 26.5% (England 23.1%).

    Pathways within standard (%)BlackpoolLancashireof Morecambe BayLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)71.3882.9078.3978.3979.32
    31-day treatment (96%)97.9689.4395.2293.6292.50
    62-day referral to treatment (85%)67.4875.0472.3573.6271.16
    Diagnostic waits over 6 weeks (%)BlackpoolLancashireof Morecambe BayEngland
    MRI21.802.414.0421.40
    CT16.4914.9713.769.92
    Echocardiography7.5713.8510.5528.48
    Colonoscopy13.080.000.6030.83
    Gastroscopy12.470.001.4529.02
    All 15 DM01 tests26.5426.6510.4423.14
    Community services activityBlackpool residentsLancashire and South Cumbria ICB
    Care contacts28,770193,720
    Referrals4,70029,855
    Patients with a contact8,92565,335

    Community services (residents of Blackpool), Jun 2026 (provisional). In Jun 2026 (provisional), community health service providers recorded 28,770 care contacts for Blackpool residents, involving 8,925 individual patients and 4,700 referrals. Across NHS Lancashire and South Cumbria Integrated Care Board, activity reached 193,720 contacts and 65,335 patients. Adults aged 65+ accounted for 58.1% of Blackpool residents' contacts. These experimental figures represent resident and system-level community activity rather than dedicated PCN delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practices show a 26.4 pp immunisation spread despite a 1.8 pp deprivation difference

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    North Shore10636.159.4%66.9%76.8%
    Glenroyd12334.342.0%68.7%66.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBlackpool (LAD)AssetPCNBlackpool (LAD)
    Care homes (catchment)32 (874 beds)n/aSchools (catchment)45n/a
    Children's centres413Places of worship2362
    Libraries18Food banks (VCS)11
    Children and young people (VCS)n/a1Primary schools (LA maintained)35
    Primary academies1026Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and prescribing recall

    Asthma reviews cover 61.4% of the 2,104 register (England 65.7%; ICB 65.0%), leaving 812 (about 810) unreviewed; youth prescribing is 2,555 per 1,000 (England 1,488). For discussion: the PCN could run structured asthma recall using a single template, prioritising high-prescribing children with after-school slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster recall

    In Q1 2025/26, age-5 MMR2 coverage is 86.0% (cohort 57), 9 pp below the 95.0% target and 5.2 pp below MMR1 (91.2%), with a 10.5 pp difference at Glenroyd Medical Centre. For discussion: practices could audit age-5 cohorts for missed second MMR doses and run flexible pre-school catch-up clinics. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Hypertension BP and diabetes statin recall

    On a 5,978 hypertension register (21.5% vs England 15.2%), recent BP readings reach 86.9% vs England 90.0% (-3.0 percentage points); statins in diabetes aged 40+ without CVD reach 68.4% vs England 73.2% (-4.7 percentage points). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Joint frailty and complex care review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Joint Core20 physical health outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health check outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Breast screening uptake initiative (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Practice access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Hypertension BP and diabetes statin recall (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15